Citigroup’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136K Sell
4,517
-2,383
-35% -$77.1K ﹤0.01% 4167
2025
Q4
$239K Sell
6,900
-218,410
-97% -$7.71M ﹤0.01% 3913
2025
Q3
$8.19M Sell
225,310
-409,191
-64% -$13.9M 0.01% 1634
2025
Q2
$19.9M Sell
634,501
-4,787
-0.7% -$149K 0.01% 957
2025
Q1
$19M Buy
639,288
+6,344
+1% +$190K 0.01% 1002
2024
Q4
$18.7M Buy
632,944
+616,912
+3,848% +$19.5M 0.02% 1000
2024
Q3
$499K Buy
16,032
+6,299
+65% +$229K ﹤0.01% 3728
2024
Q2
$330K Sell
9,733
-12,762
-57% -$651K ﹤0.01% 3639
2024
Q1
$1.46M Buy
22,495
+18,356
+443% +$1.26M ﹤0.01% 2711
2023
Q4
$283K Buy
4,139
+1,148
+38% +$59.7K ﹤0.01% 3752
2023
Q3
$155K Sell
2,991
-671
-18% -$39.7K ﹤0.01% 3775
2023
Q2
$220K Buy
3,662
+3,322
+977% +$190K ﹤0.01% 3850
2023
Q1
$16.8K Sell
340
-6
-2% -$337 ﹤0.01% 4565
2022
Q4
$19.7K Buy
+346
New +$19.5K ﹤0.01% 4602

Other funds holding IMCR